Understanding the Alkylation of a Phenol by 1-(3-Chloropropyl)pyrrolidine: Evidence for the Intermediacy of an Azetidinium Ion.


Journal

The Journal of organic chemistry
ISSN: 1520-6904
Titre abrégé: J Org Chem
Pays: United States
ID NLM: 2985193R

Informations de publication

Date de publication:
19 04 2019
Historique:
pubmed: 9 11 2018
medline: 9 11 2018
entrez: 9 11 2018
Statut: ppublish

Résumé

The final synthetic step in the synthesis of cediranib, AZD2171, 1, is the alkylation of a phenol with an alkyl halide to generate an ether. Our need to understand and control the formation of synthetic impurities generated in this step of the synthesis led us to investigate the kinetics and mechanism of the alkylation of indolphenol, 2, 4-[(4-fluoro-2-methyl-1 H-indol-5-yl)oxy]-6-methoxyquinazolin-7-ol, by chloropyrrolidine, 3, 1-(3-chloropropyl)pyrrolidine. Studies in 1-methyl-2-pyrrolidinone (NMP) established that the active alkylating agent is the azetidinium ion, 4, 4-azoniaspiro[3.4]octane, formed via a slow intramolecular cyclization reaction of chloropyrrolidine, 3. The azetidinium ion was isolated as its tetraphenylborate salt from water by heating 3 in the presence of aqueous potassium tetraphenyl borate, and its competence as an intermediate was demonstrated by its fast reaction with 2 to yield cediranib, 1.

Identifiants

pubmed: 30404447
doi: 10.1021/acs.joc.8b02458
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4754-4762

Auteurs

Ian W Ashworth (IW)

Pharmaceutical Technology & Development , AstraZeneca , S41/11 Etherow, Silk Road Business Park , Macclesfield , SK10 2NA , United Kingdom.

Lai C Chan (LC)

Pharmaceutical Technology & Development , AstraZeneca , S41/11 Etherow, Silk Road Business Park , Macclesfield , SK10 2NA , United Kingdom.

Brian G Cox (BG)

Pharmaceutical Technology & Development , AstraZeneca , S41/11 Etherow, Silk Road Business Park , Macclesfield , SK10 2NA , United Kingdom.

Ian M McFarlane (IM)

Pharmaceutical Technology & Development , AstraZeneca , S41/11 Etherow, Silk Road Business Park , Macclesfield , SK10 2NA , United Kingdom.

Andrew R Phillips (AR)

Early Product Development, Pharmaceutical Sciences, IMED Biotech Unit , AstraZeneca , Silk Road Business Park , Macclesfield , SK10 2NA , United Kingdom.

Classifications MeSH